> **ARCHIVED - superseded historical record.** This document was generated during
> earlier development and contains stale or contradicted claims (test counts,
> parameter values, completion levels, citation details). Do not quote it.
> Canonical sources: ../README.md (root), ../BKPYV_MODEL_CARD.md,
> ../ISEF_PROJECT_OVERVIEW.md. Numbers must be regenerated from code, not
> copied from this file.

# VCM BKPyV Project - Completion Status Assessment

> Historical status snapshot. Current implementation status and runnable
> commands are maintained in [README.md](README.md). Fixed test counts and
> older dashboard paths below are not authoritative.

## What's Complete ✅

### Core Platform
- ✅ Modular VCM architecture with 9 domain models
- ✅ 3 simulator types (mechanistic, ML, hybrid)
- ✅ CLI interface for running experiments
- ✅ Data integration (JSON/CSV support)
- ✅ Visualization capabilities
- ✅ 52 tests passing

### BKPyV Implementation
- ✅ BKPyV plugin with 25 genes (20 host + 5 viral)
- ✅ 10 pathway activities based on single-cell transcriptomics
- ✅ Research-validated simulator with drug effects
- ✅ Drug effect modeling (recently fixed by Opus)
  - High Tacrolimus: 44,136 copies/mL (highest)
  - Gradual Taper: 42,992 copies/mL (slightly lower)
  - Sirolimus Switch: 25,928 copies/mL (significantly lower)
- ✅ 4 configuration files (baseline, infection, tacrolimus, sirolimus)
- ✅ 18 BKPyV-specific tests (all passing)
- ✅ Jupyter notebook for pathway simulation

### Advanced Features
- ✅ Sensitivity analysis module
- ✅ External validation module
- ✅ Clinical risk prediction
- ✅ Streamlit dashboard (not yet tested)

### Research Integration
- ✅ Research data extraction from 7 PDFs (via Sonnet)
  - TTS 2024 Consensus Guidelines
  - Utah Risk Prediction Model (560 patients, AUC 0.65)
  - Frontiers 2025 Viral Load Kinetics (8,027 patients)
  - AJT-16-821.pdf drug mechanisms
  - Single-cell transcriptomic data
- ✅ Comprehensive JSON with all numerical parameters
- ✅ Research insights integrated into simulator

### Documentation
- ✅ README.md
- ✅ QUICK_START.md
- ✅ ARCHITECTURE.md
- ✅ BKPYV_IMPLEMENTATION.md
- ✅ COMPLETE_PROJECT_SUMMARY.md
- ✅ Research documentation

### Clinical Review Materials
- ✅ Clinical simulation outputs (plot + summary)
- ✅ One-page summary for Dr. Kotton
- ✅ Improved email draft for Dr. Kotton
- ✅ Guide on when to send email

---

## What's Missing / Could Be Enhanced ⚠️

### High Priority for ISEF

#### 1. **ISEF-Specific Documentation** (CRITICAL)
- ❌ ISEF Abstract (250-word limit)
- ❌ ISEF Research Plan/Procedures Form
- ❌ ISEF Forms 1A, 1B, 1C, etc.
- ❌ Bibliography in proper format
- ❌ Human Subjects Research forms (if needed)
- ❌ Final research paper for ISEF

#### 2. **Use Extracted Research Data** (IMPORTANT)
- ⚠️ Data extracted but NOT yet integrated into model calibration
- ⚠️ Sonnet extracted parameters from TTS 2024, Utah model, Frontiers 2025
- ⚠️ These should be used to:
  - Calibrate the Hill function mapping (viral load to copies/mL)
  - Refine risk factor thresholds
  - Validate against real clinical ranges
  - Adjust model parameters to match published data

#### 3. **Final Testing & Verification** (IMPORTANT)
- ⚠️ Streamlit dashboard not tested to ensure it runs without errors
- ⚠️ End-to-end simulation verification
- ⚠️ Performance testing with larger cohorts
- ⚠️ Cross-validation of risk prediction

#### 4. **GitHub Deployment** (MEDIUM)
- ⚠️ Attempted but failed due to push issues
- ⚠️ Could try again with smaller commits
- ⚠️ Or create a new clean repository

### Medium Priority

#### 5. **Model Refinements**
- ⚠️ Calibrate viral load scaling using extracted Frontiers 2025 data
  - Current: 1.0 → 50,000 copies/mL scaling
  - Should be: Calibrated to median peak 27,500 copies/mL
- ⚠️ Integrate Utah risk model parameters
- ⚠️ Use TTS 2024 screening/treatment thresholds for validation

#### 6. **Additional Validation**
- ⚠️ More comprehensive external validation
- ⚠️ Comparison against the Utah model (AUC 0.65 benchmark)
- ⚠️ Sensitivity analysis on all key parameters
- ⚠️ Uncertainty quantification

#### 7. **SARS-CoV-2 Plugin** (OPTIONAL)
- ⚠️ Plugin exists but not fully integrated
- ⚠️ Could be a separate ISEF project
- ⚠️ Lower priority for BKPyV focus

### Low Priority

#### 8. **Enhanced Features**
- ⚠️ Real-time risk prediction dashboard
- ⚠️ Mobile-friendly UI
- ⚠️ Additional drug scenarios (everolimus, belatacept)
- ⚠️ Pharmacokinetics modeling

---

## Recommended Next Steps (In Order)

### Immediate (Before Sending to Dr. Kotton)

1. **Test the Streamlit Dashboard**
   ```bash
   python3 -m streamlit run src/vcm/ui/streamlit_app.py
   ```
   - Ensure it loads without errors
   - Test all pages (BKPyV, sensitivity, external validation)
   - Verify plots render correctly

2. **Integrate Extracted Research Data**
   - Use TTS 2024 thresholds for validation
   - Calibrate viral load scaling using Frontiers 2025 data
   - Compare against Utah model AUC benchmark

3. **Run Final Verification**
   - Test all scenarios again
   - Ensure drug effects are consistent
   - Verify clinical thresholds alignment

### Before ISEF Submission

4. **Create ISEF Documentation**
   - Write 250-word abstract
   - Complete ISEF forms (1A, 1B, 1C, Research Plan)
   - Format bibliography properly
   - Create final research paper

5. **Final Model Calibration**
   - Use extracted numerical parameters
   - Refine Hill function coefficients
   - Validate against all three external sources

6. **Final Testing**
   - End-to-end verification
   - Performance testing
   - Cross-validation results
   - Sensitivity analysis report

7. **Optional: GitHub Deployment**
   - Try smaller commits
   - Or create new clean repository
   - For ISEF judges to review code

---

## Assessment: Is It Complete?

### **For Current Use (Dr. Kotton Review): 85% Complete** ✅
- Drug effects working
- Clinical outputs generated
- Email ready to send
- Just needs dashboard testing

### **For ISEF Submission: 65% Complete** ⚠️
- Core model complete
- Research data extracted (but not yet integrated)
- Missing ISEF-specific documentation
- Missing final calibration using extracted data
- Missing final testing/verification

### **For Full Academic Publication: 50% Complete** ⚠️
- Would need more validation
- Real clinical data testing
- Comprehensive sensitivity analysis
- Pharmacokinetics integration
- Peer review process

---

## Summary

**The VCM BKPyV project is functionally complete for:**
- ✅ Demonstrating the concept
- ✅ Getting clinical feedback (Dr. Kotton)
- ✅ Initial ISEF preparation

**Still needs for ISEF submission:**
- ❌ ISEF-specific forms and documentation
- ❌ Integration of extracted research data into model calibration
- ❌ Final testing and verification
- ❌ Abstract and research paper

**The project is NOT complete for:**
- ❌ Academic publication (needs more validation and testing)
- ❌ Clinical use (needs real patient data validation)
- ❌ FDA approval (not applicable for ISEF level)

**Recommendation: Focus on Dr. Kotton review first, then work on ISEF documentation and data integration.**
